ITI Life Sciences is a unique,
entrepreneurial organisation which creates, funds and manages early
stage research and development programmes to generate market-focused
intellectual assets for exploitation by existing and new companies.
Do you have a track record
of innovation in one of these areas: ophthalmology; drug delivery; biologics;
medical devices; or nanotechnology? If so we’d like to meet you!
We are looking for researchers who can contribute to an ITI sponsored
international research programme that is focused on the development
of disruptive technology to enable intra-ocular delivery of biopharmaceuticals
and diagnostics.
What we need from
you
ITI will shortly host a
programme-scoping workshop involving a number of internationally recognised
academic and commercial experts to explore areas of convergence and
potential innovation in the intra-ocular delivery space.
The meeting is expected
to lead to the formation of an international collaboration, sponsored
by ITI Life Sciences, and the initiation of an R&D programme, typically
funded to around £3-10 million ($6-20 million) over 3 years.
All relevant information relating to the Call can be downloaded from
the link below:
Download Call Document (PDF
492KB)
To submit a response to the Call please complete the template found at
the link below:
Download
Response Template (Word 120KB)
Call responses should be emailed to IOD@itilifesciences.com no later
than the June 2, 2008.
To date, ITI Life Sciences has invested over £50 million in 5 research
programmes in the fields of stem cell technologies, text mining, transgenic
screening and safety models, cardiac biomarkers and lifetime fluorescence
assays. Most recently ITI has instigated a drug discovery programme focused
on Ubiquitin Signalling.
We have a proven track-record of working with entrepreneurial
companies and academic groups to create real innovation with a commercial
focus by crafting exciting collaborative programmes.
Please direct all questions regarding this call to martyn.link@itilifesciences.com